Do Mitochondrial DNA Mutations and Aging Share a Hidden Cellular Driver?

Researchers have linked the sudden spike of mitochondrial DNA mutations and aging to clonal expansion in blood cells, shifting the paradigm of how we track cellular decay. By analysing whole-genome sequences from approximately 750,000 individuals, the study measured a sharp rise in low-level mitochondrial single-nucleotide variants (mtSNVs) past age 60. While older methods relied on detecting oxidative lesions to explain mitochondrial decline, this new approach leverages massive-scale genomic sequencing to call low-frequency heteroplasmic variants directly from blood samples.

Historically, researchers blamed oxidative stress for mitochondrial decay. This study suggests a different origin: simple replication errors that remain hidden in bulk tissue until age-related clonal expansion in blood causes specific cell clones to multiply, rendering these 'cryptic' mutations visible. It is a brilliant mechanistic unification of cellular aging markers, though the reliance on blood-only data remains a clear limitation.

The Cellular Link Between Mitochondrial DNA Mutations and Aging

The team measured genetic associations between high mutation loads and clonal haematopoiesis (CH) driver genes, including TERT and TCL1A. These mutations exhibit little evidence of positive selection, suggesting they are predominantly neutral. However, the study does not settle whether these mutations actively drive the physical decline of aging or merely act as passive passengers of clonal expansion. Furthermore, because the study analysed blood, these findings are strictly limited to the haematopoietic system and may not apply to post-mitotic tissues like brain or muscle.

This discovery positions mitochondrial DNA as a highly sensitive biomarker for somatic mosaicism. The implications suggest three main shifts in how we view cellular aging:

• Refutes the classic oxidative damage theory of mitochondrial mutation accumulation.
• Identifies germline variants near TERT and SMC4 as regulators of mutation visibility.
• Establishes mitochondrial sequencing as a potential proxy for detecting blood-system aging.